Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF.

Pediatric Pulmonology
Marie E Egan

Abstract

Although effective cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy has the potential to change the lives of many patients with cystic fibrosis (CF), it is unlikely that these drugs will be a game changing therapy for all. There are about 10% of patients with CF who don't produce a mutant protein tomodulate, potentiate, or optimize and for these patients such therapies are unlikely to be of significant benefit. There is a need to develop new therapeutic approaches that can work for this patient population and can advance CF therapies. These new therapies will be genetic-based therapies and each approach will result in functional CFTR protein inpreviously affected CF cells. In this review we will examine the potential of RNA therapies, gene transfer therapies, and gene editing therapies for the treatment of CF as well as the challenges that will need to be facedas we harness the power of these emerging therapies towards a one-time cure.

References

Dec 19, 2009·The New England Journal of Medicine·Jean Bennett
Aug 31, 2012·Stem Cells and Development·Sivaprakash RamalingamSrinivasan Chandrasegaran
Sep 27, 2013·The New England Journal of Medicine·Michael J HarrisonBarry J Plant
May 20, 2014·The Lancet. Respiratory Medicine·Eitan KeremUNKNOWN Cystic Fibrosis Ataluren Study Group
Feb 6, 2015·Nature Protocols·Sarah X L HuangHans-Willem Snoeck
Jul 8, 2015·The Lancet. Respiratory Medicine·Eric W F W AltonUNKNOWN UK Cystic Fibrosis Gene Therapy Consortium
Dec 2, 2015·American Journal of Respiratory and Critical Care Medicine·Eric W F W AltonUNKNOWN UK Cystic Fibrosis Gene Therapy Consortium *
Sep 2, 2016·Current Opinion in Pulmonary Medicine·Uta GriesenbachEric Alton
Oct 5, 2016·JCI Insight·Benjamin SteinesJoseph Zabner
Jul 6, 2017·Frontiers in Pharmacology·Fernando A L MarsonJosé D Ribeiro
Nov 2, 2017·The New England Journal of Medicine·Jerry R MendellBrian K Kaspar
Nov 4, 2017·The New England Journal of Medicine·Steven M RoweJane C Davies
Nov 13, 2017·Current Opinion in Pharmacology·Yifat S OrenIsabelle Sermet-Gaudelus
Nov 22, 2017·Nucleic Acid Therapeutics·Shruti Sasaki, Shuling Guo
Mar 15, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Adele S RicciardiPeter M Glazer
Jun 19, 2018·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ema RobinsonGaurav Sahay
Aug 7, 2018·Nature Biotechnology·Cormac Sheridan
Oct 20, 2018·The New England Journal of Medicine·Dominic KeatingUNKNOWN VX16-445-001 Study Group
Oct 20, 2018·The New England Journal of Medicine·Jane C DaviesUNKNOWN VX16-659-101 Study Group
Dec 14, 2018·Nature Medicine·Hannah Stower
Feb 20, 2019·Nature Communications·John D LueckChristopher A Ahern
Feb 26, 2019·Frontiers in Pharmacology·Andrew BericalFinn Hawkins
Mar 16, 2019·Frontiers in Pharmacology·Iwona PrankeIsabelle Sermet-Gaudelus
Apr 2, 2019·Current Opinion in Biomedical Engineering·Melissa P LokugamageJames E Dahlman
May 10, 2019·The Journal of Investigative Dermatology·M Peter Marinkovich, Jean Y Tang
Jun 14, 2019·Genes & Diseases·Craig A Hodges, Ronald A Conlon
Aug 30, 2019·Advanced Materials·Melissa P LokugamageJames E Dahlman
Oct 3, 2019·The Application of Clinical Genetics·Garyfalia Karponi, Nikolaos Zogas
Oct 4, 2019·Nature Biotechnology·Charlotte Harrison

❮ Previous
Next ❯

Citations

May 1, 2021·Antibiotics·Rosa María Girón MorenoRosa Mar Gómez-Punter
Jun 1, 2021·Frontiers in Pharmacology·Anna M van HeeckerenTracey L Bonfield

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Molecular Sciences
Christelle Bergeron, André M Cantin
Expert Opinion on Emerging Drugs
Reshma Amin, Felix Ratjen
© 2021 Meta ULC. All rights reserved